Lista de obras - John Minna - Dominio Público Uruguay

A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer

artículo científico publicado en 2020

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer

artículo científico publicado en 2021

Characterizing the cancer genome in lung adenocarcinoma

artículo científico publicado en 2007

Different Originating Cells Underlie Intertumoral Heterogeneity in Lung Neuroendocrine Tumors

scientific article published on 01 October 2018

Establishment of reference standards for multifaceted mosaic variant analysis

publication published on 03 February 2022

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

artículo científico publicado en 2021

HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress

scientific article published on 05 September 2018

IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells

scientific article published on 15 October 2013

Inhibition of thioredoxin/thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis

artículo científico publicado en 2018

Kub5-Hera Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers

artículo científico publicado en 2018

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma

scientific article published on 30 April 2019

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations

artículo científico publicado en 2021

Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications

scientific article published on 15 March 2022

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

artículo científico publicado en 2015

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.

scientific article published on 29 December 2016

Phosphatidylserine receptors enhance SARS-CoV-2 infection

artículo científico publicado en 2021

SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-Deoxyguanosine

scientific article published on 16 January 2020

Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells

artículo científico publicado en 2014

The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer

artículo científico publicado en 2020

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs

artículo científico publicado en 2014

Validation of the 12-gene predictive signature for Adjuvant Chemotherapy Response in Lung Cancer

article

Lista de obras de John Minna

A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer

Characterizing the cancer genome in lung adenocarcinoma

Different Originating Cells Underlie Intertumoral Heterogeneity in Lung Neuroendocrine Tumors

Establishment of reference standards for multifaceted mosaic variant analysis

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress

IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells

Inhibition of thioredoxin/thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis

Kub5-Hera Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations

Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.

Phosphatidylserine receptors enhance SARS-CoV-2 infection

SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-Deoxyguanosine

Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells

The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs

Validation of the 12-gene predictive signature for Adjuvant Chemotherapy Response in Lung Cancer